News

March 6, 2018March 6, 2018

Signaling from Nervous System Helped Control Inflammatory Response in IBD, Mouse Study Shows

News

Signaling from the nervous system through the β2-adrenergic receptor can help control the type of inflammation that characterizes inflammatory bowel disease (IBD), a new mouse study shows. These findings suggest ... Read more

March 5, 2018

Entyvio Outperforms Anti-TNF Alpha Therapies in Real-world Bowel Disease Studies

News

Real-world treatment results showed that Takeda’s Entyvio (vedolizumab) was better than an anti-tumor necrosis factor-alpha therapy at alleviating moderate to severe ulcerative colitis or Crohn’s disease, according to several studies. They ... Read more

March 2, 2018March 6, 2018

2018 Sherman Prize Now Accepting Nominations for Exceptional, Pioneering Work in Crohn’s and Colitis

News

The Bruce and Cynthia Sherman Charitable Foundation is now accepting nominations for the 2018 Sherman Prize, which rewards exceptional individuals who make pioneering contributions in the fight to overcome two inflammatory ... Read more

February 27, 2018

Crohn’s and Colitis Foundation Updates Research Network, Now Called IBD Partners

News

The Crohn’s and Colitis Foundation recently updated its patient-powered research network, formerly known as CCFA Partners and now known as IBD Partners. IBD Partners is an online registry of more ... Read more

February 26, 2018

IBD Patients with Iron Deficiency Treated Intravenously Had More Clinical, Cost Benefits, Study Finds

News

Researchers found that patients with inflammatory bowel disease (IBD) with iron deficiency (ID) or iron deficiency anemia (IDA) who were administered iron intravenously were hospitalized less frequently and had lower ... Read more

February 23, 2018

Otezla Shows Promise in Treating Ulcerative Colitis Patients in Phase 2 Clinical Trial, Company Says

News

Otezla (apremilast), developed by Celgene Corporation, showed promising results in a group of active ulcerative colitis (UC) patients in a Phase 2 clinical trial, the company recently announced. Participants in the ... Read more

February 20, 2018

FDA OKs Clinical Trial to Test Bacteriophage-Based Treatment for Crohn’s

News

The U.S. Food and Drug Administration (FDA) recently cleared a Phase 1/2a clinical trial to study a set of bacteriophages designed to treat inflammatory bowel diseases (IBDs), specifically Crohn’s disease. ... Read more

February 19, 2018

Regentys and Cook Partnering on Ongoing Development of Ulcerative Colitis Therapy

News

Regentys and Cook Biotech are teaming up to continue developing a treatment for the inflammatory bowel disease ulcerative colitis. Under the agreement, Cook will direct the development of Regentys’ ECMH Rectal Solution, ... Read more

February 16, 2018

Migration and Race May Play a Role in the Development of IBD

News

A recent review suggests that migration and race influence the risk of developing inflammatory bowel disease. In particular, South Asian migrants have a consistently higher incidence of ulcerative colitis and ... Read more

February 13, 2018

Takeda and Cedars-Sinai Create IBD&ME App to Help Patients Make Treatment Choices

News

Takeda and Cedars-Sinai have joined forces to develop an online tool that uses a marketing technique to create personalized profiles to help inflammatory bowel disease (IBD) patients sort through treatments ... Read more